A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Condition:   Type 2 Diabetes MellitusInterventions:   Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Glipizide;   Drug: Placebo to glipizide;   Biological: InsulinSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2012 Category: Research Source Type: clinical trials

A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Condition:   Type 2 Diabetes MellitusInterventions:   Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Glipizide;   Drug: Placebo to glipizide;   Biological: InsulinSponsor:   Merck Sharp & Dohme Corp.Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2012 Category: Research Source Type: clinical trials

A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Condition:   Type 2 Diabetes MellitusInterventions:   Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Glipizide;   Drug: Placebo to glipizide;   Biological: InsulinSponsor:   Merck Sharp & Dohme Corp.Active, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2012 Category: Research Source Type: clinical trials

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients
Condition:   Type 2 DiabetesInterventions:   Drug: dapagliflozin;   Drug: glipizide;   Drug: metformin hydrochlorideSponsors:   AstraZeneca;   Bristol-Myers SquibbCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2008 Category: Research Source Type: clinical trials

MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)
Condition:   Diabetes Mellitus, Type 2Intervention:   Drug: MK0767Sponsor:   Merck Sharp & Dohme Corp.Terminated - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2007 Category: Research Source Type: clinical trials